By Matt Grossman

 

Synlogic Inc. and Roche Holding AG will collaborate on research into a treatment for inflammatory bowel disease, Synlogic said Thursday.

Following the research period established by the agreement, Roche will have an exclusive option for a licensing and collaboration agreement for further development and commercialization, according to Synlogic, a Cambridge, Mass. based pharmaceutical company.

 

Write to Matt Grossman at matt.grossman@wsj.com

 

(END) Dow Jones Newswires

June 17, 2021 07:56 ET (11:56 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Roche (QX) Charts.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Roche (QX) Charts.